saratchanderRO Profile Banner
Sarat Chander Profile
Sarat Chander

@saratchanderRO

Followers
237
Following
102
Media
12
Statuses
161

Radiation Oncologist , @UniMelb @PeterMacRadOnc @AusBrachy @anzsarcoma Brachytherapist, SABRist

Melbourne Australia
Joined August 2011
Don't wanna be here? Send us removal request.
@saratchanderRO
Sarat Chander
2 years
Partially Ablative Body Radiotherapy (PABR): A novel approach for pall... https://t.co/O40IBGe9I5 Kudos to the PABR team and @PeterMacRadOnc fellow @kelvinkenyu to get this to @RadiotherapyOn1 .Effective palliation for these unfortunate patients. Now onto the prospective trial!
4
15
35
@saratchanderRO
Sarat Chander
1 year
Should ovarian tissue be harvested and stored before radiation to the pelvis in an adult woman? Can such a uterus successfully carry a pregnancy to term, even if I managed to spare only part of the uterus? Questions that arose in my mind in 2016. https://t.co/NnS7A1Bwnx
0
0
2
@saratchanderRO
Sarat Chander
2 years
Link to the paper now available
0
2
8
@saratchanderRO
Sarat Chander
2 years
9 month scan of a 80 year old with synovial sarcoma overlayed on planning CT - shows a 78% reduction! Toxicity only fatigue! Purple is post PABR volume
0
5
17
@saratchanderRO
Sarat Chander
2 years
Thanks to @anzsarcoma,@PeterMacCC Foundation and Victorian Cancer Agency for ongoing support for the next stage of this !
@saratchanderRO
Sarat Chander
2 years
Partially Ablative Body Radiotherapy (PABR): A novel approach for pall... https://t.co/O40IBGe9I5 Kudos to the PABR team and @PeterMacRadOnc fellow @kelvinkenyu to get this to @RadiotherapyOn1 .Effective palliation for these unfortunate patients. Now onto the prospective trial!
0
1
7
@mikemejiamd
Michael Mejia
2 years
Deepening the Philippine #radonc bench
@AusBrachy
Australasian Brachytherapy Group
2 years
#ABG2024 Hobart Rad Onc fellow Kelvin Yu @kelvinkenyu 🇵🇭 presenting on behalf of @PeterMacRadOnc urol/brachy team, the intricacies of salvage treatment. His fellowship has been so rewarding for us all. Sad to say goodbye.
0
2
9
@AusBrachy
Australasian Brachytherapy Group
2 years
#ABG2024 Hobart @angelo_tzovaras presenting proof of concept on the potential of 3D ultrasound to guide gynae brachytherapy. Perhaps IGABT can be more accessible in a regions with low resources. @PeterMacRadOnc @GlobalRadOnc @pixiepk1
1
3
5
@AusBrachy
Australasian Brachytherapy Group
2 years
#ABG2024 Hobart Rad Onc fellow Kelvin Yu @kelvinkenyu 🇵🇭 presenting on behalf of @PeterMacRadOnc urol/brachy team, the intricacies of salvage treatment. His fellowship has been so rewarding for us all. Sad to say goodbye.
1
3
11
@9NewsMelb
9News Melbourne
2 years
There's hope surgeons will soon be able to find and remove cancers with greater accuracy. A molecule is being tested in Melbourne which makes tumours glow green under infrared light. @msanto92 #9News
7
9
30
@_ShankarSiva
Shankar Siva
2 years
🔥@ErinGillespieMD randomized trial of SoC +/- #radiotherapy, n=78 with 122 high-risk bone metastases, mixed histology, - ⬇️ Skeletal-related events 1.6% vs 22% (p<0.001) - ⬆️OS - HR [0.49] with RT, p=0.018 👏👏👏 amazing outcomes #radonc!! #lungcancer https://t.co/2HGPXju9n7
9
76
189
@sylvia_vandyk
Sylvia van Dyk
2 years
It’s that time! ABG2024 registration is open. Join us in beautiful Hobart in February. @AusBrachy @sylviahanna18 @BusuttilGemma @Yarraben @JPoderMedPhys @angelo_tzovaras @saratchanderRO @pixiepk1 @DavidCh88224451
0
6
12
@saratchanderRO
Sarat Chander
2 years
Dr Kelvin Ken Yu our fellow presenting Peter Mac experience in patients with radiorecurrent prostate cancer treated with salvage SABR or salvage HDR brachytherapy.
0
3
18
@sylvia_vandyk
Sylvia van Dyk
3 years
Congrats to our former GI Gellow @ryanagasmd on publishing this update to @PeterMacRadOnc brachytherapy IORT program for Locally Advanced and Recurrent Colorectal Cancer https://t.co/h91g7KeCUT #ThisIsBrachytherapy @AusBrachy
1
7
15
@VedangMurthy
Vedang Murthy
3 years
Full text is here if you wish https://t.co/8AxXNv3R9B
@VedangMurthy
Vedang Murthy
3 years
The first truly collaborative effort in #ProstateCancer RT from India 🇮🇳. ✅ 19 centers, n=462 ✅ All GG5, 80 %T3/4, 30% N+ ✅ All EBRT+ADT, no brachy. Med FU 56 m 💥 5-yr MFS, OS = 77.4%, 90.5% (not bad! 😊) 💥 On MVA Primary Gl 5 (5+5 & 5+4) worse than primary Gl 4 (4+5).
2
6
19
@saratchanderRO
Sarat Chander
3 years
How true!!! Brachytherapy where real and artificial intelligence is in your hands!
@sylvia_vandyk
Sylvia van Dyk
3 years
So lovely to see you in Marvellous Melbourne and @PeterMacCC @Sushilberiwal - as you say, adaptive RT has been a thing in brachy forever @AusBrachy @PeterMacRadOnc @saratchanderRO @pixiepk1 @DavidCh88224451 @VarianMedSys 🙏
1
1
9
@PBlanchardMD
Pierre Blanchard, MD
3 years
Outcomes following high dose rate #brachytherapy boost for high/intermediate risk #ProstateCancer. Our report shows high efficacy (85% bPFS at 5 years in high risk patients) with low toxicity (HDR better than seeds?). In press @RadiotherapyOn1 https://t.co/Z8J7ZjJYcC
6
27
83
@saratchanderRO
Sarat Chander
3 years
Listening to Carols while awaiting Radiotherapy ⁦@PeterMacRadOnc⁩ Box Hill Campus!
0
1
20
@saratchanderRO
Sarat Chander
3 years
Kudos to @_ShankarSiva who has led Our #SABR @PeterMacRadOnc most ably.🙏
@svporceddu
Sandro Porceddu
3 years
Shankar Siva providing annual ⁦@PeterMacRadOnc⁩ ⁦@PeterMacCC#SABR wrap up- single 30Gy dose to oligo lung met-we’ve come a long way ⁦@_ShankarSiva⁩ ⁦@TargetingCancer⁩ ⁦@TROGfightcancer
0
1
9
@KrishanJethwa
Krishan Jethwa
3 years
🔥🔥🔥 Eagerly awaited results of RTOG 1112 demonstrating the important role RT has in the care of pts with HCC Sorafenib +/- SBRT 🔵OS: 12.3m vs 15.8m Congratulations!!! @nrgonc @ldawsonmd #ASTRO22
3
58
147
@DrSpratticus
Daniel E Spratt
3 years
@saratchanderRO⁩ opening up #FROGG22 in Hobart Tasmania! Going to be an incredible meeting with the GU faculty of Australia and New Zealand!
4
2
34